Chard Daniel R.'s most recent trade in Medifast Inc was a trade of 381 Common Stock done at an average price of $13.1 . Disclosure was reported to the exchange on June 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 13.13 per share. | 13 Jun 2025 | 381 | 149,698 (1%) | 0% | 13.1 | 5,003 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 124,953 | 176,246 (1%) | 1% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.87 per share. | 13 Mar 2025 | 5,001 | 54,101 (0%) | 0% | 13.9 | 69,364 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.35 per share. | 13 Mar 2025 | 1,864 | 51,293 (0%) | 0% | 14.3 | 26,748 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.94 per share. | 13 Mar 2025 | 944 | 53,157 (0%) | 0% | 13.9 | 13,159 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 149,317 | 149,317 (1%) | 1% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 149,317 | 0 (0%) | 1% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 108,598 | 108,598 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 108,598 | 0 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 40,719 | 149,317 (1%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 40,719 | 59,102 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 1,859 | 99,821 (0%) | 0% | 36.6 | 68,058 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 942 | 101,680 (0%) | 0% | 36.6 | 34,487 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 608 | 102,622 (0%) | 0% | 36.6 | 22,259 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 45,087 | 103,230 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Chard Daniel R. | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 16,486 | 63,614 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | R. Chard Daniel | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.68 per share. | 14 Feb 2024 | 5,471 | 58,143 (0%) | 0% | 52.7 | 288,212 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 34,076 | 48,194 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 16,807 | 47,128 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 109.99 per share. | 24 Feb 2023 | 15,643 | 32,551 (0%) | 0% | 110.0 | 1,720,574 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.46 per share. | 24 Feb 2023 | 1,358 | 31,193 (0%) | 0% | 104.5 | 141,857 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.75 per share. | 24 Feb 2023 | 872 | 30,321 (0%) | 0% | 102.8 | 89,598 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.31 per share. | 21 Feb 2023 | 1,815 | 14,118 (0%) | 0% | 115.3 | 209,288 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 183.28 per share. | 05 May 2022 | 431 | 108,598 (0%) | 0% | 183.3 | 78,995 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 8,509 | 21,139 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 180.52 per share. | 16 Mar 2022 | 878 | 20,261 (0%) | 0% | 180.5 | 158,497 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.06 per share. | 22 Feb 2022 | 1,804 | 13,912 (0%) | 0% | 177.1 | 319,416 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.06 per share. | 22 Feb 2022 | 1,282 | 12,630 (0%) | 0% | 177.1 | 226,991 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2022 | 3,375 | 16,886 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2022 | 3,375 | 107,214 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2022 | 953 | 15,933 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2022 | 953 | 108,167 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 186.47 per share. | 04 Feb 2022 | 690 | 103,839 (0%) | 0% | 186.5 | 128,667 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2021 | 90,610 | 15,716 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2021 | 90,610 | 90,610 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 260.37 per share. | 17 Jun 2021 | 1,000 | 111,091 (0%) | 0% | 260.4 | 260,374 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 261.46 per share. | 17 Jun 2021 | 1,000 | 110,091 (0%) | 0% | 261.5 | 261,456 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 263.31 per share. | 17 Jun 2021 | 863 | 108,628 (0%) | 0% | 263.3 | 227,239 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 267.00 per share. | 17 Jun 2021 | 802 | 107,326 (0%) | 0% | 267.0 | 214,135 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 262.54 per share. | 17 Jun 2021 | 600 | 109,491 (0%) | 0% | 262.5 | 157,524 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 259.32 per share. | 17 Jun 2021 | 600 | 112,091 (0%) | 0% | 259.3 | 155,594 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 268.00 per share. | 17 Jun 2021 | 502 | 106,824 (0%) | 0% | 268.0 | 134,538 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 269.12 per share. | 17 Jun 2021 | 298 | 106,526 (0%) | 0% | 269.1 | 80,197 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 265.29 per share. | 17 Jun 2021 | 287 | 108,128 (0%) | 0% | 265.3 | 76,138 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 264.35 per share. | 17 Jun 2021 | 213 | 108,415 (0%) | 0% | 264.3 | 56,306 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 270.10 per share. | 17 Jun 2021 | 200 | 106,326 (0%) | 0% | 270.1 | 54,019 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 281.83 per share. | 15 Jun 2021 | 3,514 | 119,747 (1%) | 0% | 281.8 | 990,342 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 273.03 per share. | 15 Jun 2021 | 1,410 | 115,958 (0%) | 0% | 273.0 | 384,975 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 276.35 per share. | 15 Jun 2021 | 1,019 | 113,558 (0%) | 0% | 276.4 | 281,605 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 272.13 per share. | 15 Jun 2021 | 947 | 117,368 (0%) | 0% | 272.1 | 257,704 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 282.92 per share. | 15 Jun 2021 | 811 | 118,936 (1%) | 0% | 282.9 | 229,450 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 277.32 per share. | 15 Jun 2021 | 767 | 112,791 (0%) | 0% | 277.3 | 212,706 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 278.40 per share. | 15 Jun 2021 | 752 | 124,509 (1%) | 0% | 278.4 | 209,360 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 280.89 per share. | 15 Jun 2021 | 700 | 123,261 (1%) | 0% | 280.9 | 196,623 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 274.13 per share. | 15 Jun 2021 | 700 | 115,258 (0%) | 0% | 274.1 | 191,889 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 275.12 per share. | 15 Jun 2021 | 681 | 114,577 (0%) | 0% | 275.1 | 187,359 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 279.48 per share. | 15 Jun 2021 | 548 | 123,961 (1%) | 0% | 279.5 | 153,157 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 275.84 per share. | 15 Jun 2021 | 450 | 125,461 (1%) | 0% | 275.8 | 124,128 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 284.03 per share. | 15 Jun 2021 | 421 | 118,515 (1%) | 0% | 284.0 | 119,578 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 274.51 per share. | 15 Jun 2021 | 300 | 125,911 (1%) | 0% | 274.5 | 82,353 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 276.73 per share. | 15 Jun 2021 | 200 | 125,261 (1%) | 0% | 276.7 | 55,346 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 270.49 per share. | 15 Jun 2021 | 200 | 118,315 (1%) | 0% | 270.5 | 54,098 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 279.03 per share. | 15 Jun 2021 | 100 | 112,691 (0%) | 0% | 279.0 | 27,903 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 288.21 per share. | 11 Jun 2021 | 3,264 | 136,215 (1%) | 0% | 288.2 | 940,723 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 279.56 per share. | 11 Jun 2021 | 2,267 | 130,502 (1%) | 0% | 279.6 | 633,763 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 280.30 per share. | 11 Jun 2021 | 1,907 | 128,595 (1%) | 0% | 280.3 | 534,538 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 287.41 per share. | 11 Jun 2021 | 1,847 | 139,479 (1%) | 0% | 287.4 | 530,841 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 289.30 per share. | 11 Jun 2021 | 1,563 | 134,652 (1%) | 0% | 289.3 | 452,177 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 281.44 per share. | 11 Jun 2021 | 1,038 | 127,557 (1%) | 0% | 281.4 | 292,138 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 290.88 per share. | 11 Jun 2021 | 761 | 133,891 (1%) | 0% | 290.9 | 221,356 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 278.14 per share. | 11 Jun 2021 | 521 | 132,769 (1%) | 0% | 278.1 | 144,911 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 293.12 per share. | 11 Jun 2021 | 400 | 133,290 (1%) | 0% | 293.1 | 117,246 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 289.28 per share. | 11 Jun 2021 | 343 | 126,311 (1%) | 0% | 289.3 | 99,224 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 282.06 per share. | 11 Jun 2021 | 303 | 127,254 (1%) | 0% | 282.1 | 85,464 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 283.67 per share. | 11 Jun 2021 | 300 | 126,954 (1%) | 0% | 283.7 | 85,100 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 291.61 per share. | 11 Jun 2021 | 201 | 133,690 (1%) | 0% | 291.6 | 58,613 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 291.00 per share. | 11 Jun 2021 | 100 | 126,211 (1%) | 0% | 291 | 29,100 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 287.78 per share. | 11 Jun 2021 | 100 | 126,654 (1%) | 0% | 287.8 | 28,778 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 285.74 per share. | 11 Jun 2021 | 100 | 126,754 (1%) | 0% | 285.7 | 28,574 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 284.65 per share. | 11 Jun 2021 | 100 | 126,854 (1%) | 0% | 284.7 | 28,465 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2021 | 5,495 | 141,326 (1%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 494.00 per share. | 19 Feb 2021 | 1 | 137,140 (1%) | 0% | 494 | 494 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 351.00 per share. | 19 Feb 2021 | 1 | 135,831 (1%) | 0% | 351 | 351 | Common Stock |